Natasha Leighl, MD, MMSC, FRCPC, FASCO
Natasha Leighl, MD, FRCPC, FASCO,
Lung Site Lead, Medical Oncology
OSI Pharmaceuticals Foundation Chair
Princess Margaret Cancer Centre
Professor of Medicine, University of Toronto
Natasha Leighl, MD, MMsc, FRCPC, FASCO, has disclosed that she has received funds for research support from Amgen, Array, AstraZeneca, Bayer, Bristol Myers Squibb, Eli Lilly, EMD Serono, Guardant Health, Inivata, MSD, Novartis, Pfizer, Roche, and Takeda and consultant/advisor/ speaker fees for Amgen, Bristol Myers Squibb, GlaxoSmithKline, MSD, Novartis, Puma Biotechnology, Sanofi Genzyme, and Takeda.